Prions: Beyond a Single Protein

被引:35
作者
Das, Alvin S.
Zou, Wen-Quan [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Natl Ctr Regenerat Med,Dept Pathol, Cleveland, OH USA
基金
美国国家卫生研究院;
关键词
CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; FATAL FAMILIAL INSOMNIA; PATHOLOGICAL ALPHA-SYNUCLEIN; CHRONIC WASTING DISEASE; MISFOLDING CYCLIC AMPLIFICATION; INDUCED CONVERSION ANALYSIS; TRANSGENIC MOUSE MODEL; TO-PERSON TRANSMISSION; CENTRAL-NERVOUS-SYSTEM;
D O I
10.1128/CMR.00046-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Since the term protein was first coined in 1838 and protein was discovered to be the essential component of fibrin and albumin, all cellular proteins were presumed to play beneficial roles in plants and mammals. However, in 1967, Griffith proposed that proteins could be infectious pathogens and postulated their involvement in scrapie, a universally fatal transmissible spongiform encephalopathy in goats and sheep. Nevertheless, this novel hypothesis had not been evidenced until 1982, when Prusiner and coworkers purified infectious particles from scrapie-infected hamster brains and demonstrated that they consisted of a specific protein that he called a "prion." Unprecedentedly, the infectious prion pathogen is actually derived from its endogenous cellular form in the central nervous system. Unlike other infectious agents, such as bacteria, viruses, and fungi, prions do not contain genetic materials such as DNA or RNA. The unique traits and genetic information of prions are believed to be encoded within the conformational structure and posttranslational modifications of the proteins. Remarkably, prion-like behavior has been recently observed in other cellular proteins-not only in pathogenic roles but also serving physiological functions. The significance of these fascinating developments in prion biology is far beyond the scope of a single cellular protein and its related disease.
引用
收藏
页码:633 / 658
页数:26
相关论文
共 364 条
[1]   A novel generation of heparan sulfate mimetics for the treatment of prion diseases [J].
Adjou, KT ;
Simoneau, S ;
Salès, N ;
Lamoury, F ;
Dormont, D ;
Papy-Garcia, D ;
Barritault, D ;
Deslys, JP ;
Lasmézas, CI .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2595-2603
[2]   MS-8209, A NEW AMPHOTERICIN-B DERIVATIVE, PROVIDES ENHANCED EFFICACY IN DELAYING HAMSTER SCRAPIE [J].
ADJOU, KT ;
DEMAIMAY, R ;
LASMEZAS, C ;
DESLYS, JP ;
SEMAN, M ;
DORMONT, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2810-2812
[3]   Probing the dynamics of prion diseases with amphotericin B [J].
Adjou, KT ;
Deslys, JP ;
Demaimay, R ;
Dormont, D .
TRENDS IN MICROBIOLOGY, 1997, 5 (01) :27-31
[4]   MS-8209, an amphotericin B analogue, delays the appearance of spongiosis, astrogliosis and PrPres accumulation in the brain of scrapie-infected hamsters [J].
Adjou, KT ;
Privat, N ;
Demart, S ;
Deslys, JP ;
Seman, M ;
Hauw, JJ ;
Dormont, D .
JOURNAL OF COMPARATIVE PATHOLOGY, 2000, 122 (01) :3-8
[5]   Mechanisms of disease - Insights into prion strains and neurotoxicity [J].
Aguzzi, Adriano ;
Heikenwalder, Mathias ;
Polymenidou, Magdalini .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (07) :552-561
[6]   Pathogenesis of prion diseases: current status and future outlook [J].
Aguzzi, Adriano ;
Heikenwalder, Mathias .
NATURE REVIEWS MICROBIOLOGY, 2006, 4 (10) :765-775
[7]  
Alzheimer A., 1907, Zentralbl. Nervenh. Psych, V64, P146, DOI DOI 10.1002/CA.980080612
[8]   Prion Strain Mutation Determined by Prion Protein Conformational Compatibility and Primary Structure [J].
Angers, Rachel C. ;
Kang, Hae-Eun ;
Napier, Dana ;
Browning, Shawn ;
Seward, Tanya ;
Mathiason, Candace ;
Balachandran, Aru ;
McKenzie, Debbie ;
Castilla, Joaquin ;
Soto, Claudio ;
Jewell, Jean ;
Graham, Catherine ;
Hoover, Edward A. ;
Telling, Glenn C. .
SCIENCE, 2010, 328 (5982) :1154-1158
[9]  
[Anonymous], 2020, BIOSAFETY MICROBIOLO
[10]   Rapidly progressive dementias and the treatment of human prion diseases [J].
Appleby, Brian S. ;
Lyketsos, Constantine G. .
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (01) :1-12